Abpro Holdings, Inc. (ABPO)
OTCMKTS · Delayed Price · Currency is USD
0.1775
+0.0148 (9.10%)
At close: May 5, 2026
Abpro Holdings Market Cap
Abpro Holdings has a market cap or net worth of $1.05 million as of May 5, 2026. Its market cap has decreased by -91.16% in one year.
Market Cap
1.05M
Enterprise Value
1.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since March 9, 2022, Abpro Holdings's market cap has decreased from 4.10B to 1.05M, a decrease of -99.97%. That is a compound annual growth rate of -86.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 1.05M | -90.89% |
| Dec 31, 2025 | 11.49M | -87.30% |
| Dec 31, 2024 | 90.44M | -97.94% |
| Dec 22, 2023 | 4.38B | 3.83% |
| Dec 30, 2022 | 4.22B | 2.93% |
| Mar 9, 2022 | 4.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sirona Biochem | 1.35M |
| Lyra Therapeutics | 1.31M |
| LakeShore Biopharma | 1.15M |
| Eastgate Biotech | 1.06M |
| Windtree Therapeutics | 967.24K |
| Eloxx Pharmaceuticals | 963.67K |
| Adaptimmune Therapeutics | 954.19K |
| Evofem Biosciences | 914.46K |